Saneca Pharmaceuticals Overview

  • Year Founded
  • 1940

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 600

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 2

Saneca Pharmaceuticals General Information

Description

Manufacturer of active pharmaceutical ingredients (APIs) and finished dosage forms based in Hlohovec, Slovakia. The company specializes in developing a variety of pharmaceutical ingredients and finished dosage forms with the help of a wide range of technology and an experienced team which develops sophisticated formulations, enabling pharmacies to receive the timely delivery of products that enhance patient compliance and product effectiveness.

Contact Information

Website
www.saneca.com
Formerly Known As
Slovakofarma, Slovak Alkaloids, Slovakofarma Hlohovec
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Nitrianska 100
  • Hlohovec, 920 27
  • Slovakia
+421 033/736
Primary Industry
Pharmaceuticals
Other Industries
Distributors (Healthcare)
Drug Discovery
Vertical(s)
Corporate Office
  • Nitrianska 100
  • Hlohovec, 920 27
  • Slovakia
+421 033/736

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saneca Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Saneca Pharmaceuticals‘s full profile, request access.

Request a free trial

Saneca Pharmaceuticals Patents

Saneca Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3713911-A1 Method for the preparation of tapentadol and its intermediates Inactive 18-Aug-2017
US-20210147434-A1 Process for the preparation of morphinane compounds Inactive 04-Jul-2017
AU-2018297073-A1 Process for the preparation of morphinane compounds Inactive 04-Jul-2017
EP-3649131-A1 Process for the preparation of morphinane compounds Inactive 04-Jul-2017
EP-3526223-B1 Method for isolation and purification of naltrexone Active 11-Oct-2016 C07D489/08
To view Saneca Pharmaceuticals’s complete patent history, request access »

Saneca Pharmaceuticals Executive Team (5)

Name Title Board Seat
Andrej Boros Controller
Jan Batka API sales director
You’re viewing 2 of 5 executive team members. Get the full list »

Saneca Pharmaceuticals Board Members (4)

Name Representing Role Since
Self Co-Vice Chairman
You’re viewing 1 of 4 board members. Get the full list »

Saneca Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Saneca Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Saneca Pharmaceuticals‘s full profile, request access.

Request a free trial

Saneca Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Stada Production Ireland 23-Jun-2015 Pharmaceuticals
Indulona 01-Jan-2015 Buyout/LBO Personal Products
To view Saneca Pharmaceuticals’s complete investments and acquisitions history, request access »

Saneca Pharmaceuticals FAQs

  • When was Saneca Pharmaceuticals founded?

    Saneca Pharmaceuticals was founded in 1940.

  • Where is Saneca Pharmaceuticals headquartered?

    Saneca Pharmaceuticals is headquartered in Hlohovec, Slovakia.

  • What is the size of Saneca Pharmaceuticals?

    Saneca Pharmaceuticals has 600 total employees.

  • What industry is Saneca Pharmaceuticals in?

    Saneca Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Saneca Pharmaceuticals a private or public company?

    Saneca Pharmaceuticals is a Private company.

  • What is Saneca Pharmaceuticals’s current revenue?

    The current revenue for Saneca Pharmaceuticals is .

  • How much funding has Saneca Pharmaceuticals raised over time?

    Saneca Pharmaceuticals has raised $2.72M.

  • Who are Saneca Pharmaceuticals’s investors?

    Middle Europe Investments, Sanofi, Slovak Ministry of Education, Science, Research and Sport, Wood & Company, and Zentiva (Prague) have invested in Saneca Pharmaceuticals.

  • When was Saneca Pharmaceuticals acquired?

    Saneca Pharmaceuticals was acquired on 01-Aug-2022.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »